CXCL12 and triple-A syndrome: These findings suggest that lowering miR206‐3p levels in the aorta effectively inhibits phenotypic transformation and apoptosis of contractile VSMCs, potentially through the suppression of the CXCL12/CXCR4 axis in AAA.